Whats New in The Medicine Cabinet - PowerPoint PPT Presentation

1 / 62
About This Presentation
Title:

Whats New in The Medicine Cabinet

Description:

Lasts about 7-8 hours. Same drug as Ambien. BUT it got FDA approval ... halibut, herring. Flax seed and nuts. Walnuts, almonds, pecans. Omacor - Prescription ... – PowerPoint PPT presentation

Number of Views:191
Avg rating:3.0/5.0
Slides: 63
Provided by: spie5
Category:

less

Transcript and Presenter's Notes

Title: Whats New in The Medicine Cabinet


1
Whats New in The Medicine Cabinet
  • Mike Spieker, M.D.Naval Hospital Bremerton

2
(No Transcript)
3
(No Transcript)
4
  • 10 chronic
  • Chronic illness
  • 2x lost days
  • 3,025 lost per employee/yr

5
(No Transcript)
6
Sleep
  • Benzodiazipines
  • Anti-histamines
  • Non-Benzos
  • Melatonin receptor agonists.
  • GABA
  • Others

7
(No Transcript)
8
  • ZZZ
  • AM
  • BIEN

9
ZZZZZZs II
  • Eszopiclone
  • Duration 8 hr
  • No tolerance
  • Cancer risk?
  • Aftertaste

10
Sleep
  • Ambien CR
  • To increase sleep duration
  • Dual release
  • Lasts about 7-8 hours
  • Same drug as Ambien BUT it got FDA approval for
    long-term use

11
The Big O
  • Rozerem
  • Melatonin agonist
  • Fall asleep, not stay asleep
  • Hypnotic effect not impressive
  • Not Schedule II
  • Cheapest retail
  • Fluvoxamine

12
Indiplon
  • Immediate CR
  • GABA receptor
  • NDA submitted
  • 50 decrease in LSO
  • 50 min increase in sTST

13
Sleep V Cost
37
46
46
44
38
30 day supply
14
  • Benadryl 2.50
  • Elavil 21
  • Trazodone 12
  • Halcion 20
  • Restoril 22

AWP 30 days
15
  • Go to sleep/wake at same time
  • Avoid caffeine late in the day
  • Watch your diet.
  • Exercise regularly.
  • Create relaxing bedtime routine
  • Get out of bed if not sleeping.

16
Insomnia Differential
  • Depression
  • Restless legs

www.sleepfoundation.org
17
Insomnia 780.52
18
  • Ropinirole
  • Dopamine agonist
  • 1 mg /day
  • No head-head trials
  • 2 retail .68 DoD

19
Table 3 NNTs for RLS treatments
20
Cholesterol
  • Crestor
  • Pitavastatin -Zomaril
  • Niaspan
  • Omega 3 Fatty Acids
  • Behavior

21
Omega 3s
  • Salmon, tuna, halibut, herring
  • Flax seed and nuts
  • Walnuts, almonds, pecans
  • Omacor - Prescription

22
Womens Health
  • Calcium / Vit D
  • Fosamax D
  • Boniva
  • DepoProvera SQ
  • Evra

23
Battle of the Bones
24
Among healthy postmenopausal women, calcium
with vitamin D supplementation resulted in a
small but significant improvement in hip bone
density, did not significantly reduce hip
fracture, and increased the risk of kidney
stones.
25
  • What are my risk factors for osteoporosis?
  • What can I do to prevent osteoporosis?
  • Am I getting enough calcium and vitamin D?
  • What is a bone mineral density test?
  • How is a bone mineral density test done? How long
    does it take? How much does it cost?
  • Should I get a bone mineral density test? What
    should I wear and where do I get tested?
  • What is a T-score? What does it tell us about my
    bone mass and risk for fracture?
  • Do I have osteopenia (thinning bones) or
    osteoporosis?
  • Im already taking calcium and vitamin D. Are
    other treatments available?

26
Coolest Pill
27
  • Monthly and daily are equi-efficacious
  • Increases bone density without GI
  • 52 Risk Reduction
  • Absolute RR lt 5
  • Cost 950-1000/yr
  • 60 minutes PC

28
975
950
1066
29
(No Transcript)
30
Numbers Needed to Treat
  • Estimates the number of patients requiring
    therapy for X time to prevent one event.

31
Relative Risk Reduction - RRR
ARR 4.9
NNT 1/ARR 1/.049 20.4
32
So..
  • To prevent one vertebral fracture, we would
    have to
  • treat 20 women
  • Asymptomatic
  • postmenopausal
  • for 3 years
  • direct cost of 58,140

Bandolier
33
Depo Provera SQ 104 PL 12-5
  • Contraception endometriosis
  • 30 less hormone
  • Bone loss risk gt 2 years
  • Wt gain 3.5 first year

34
  • 2-3x risk of clots
  • 60 more estrogen exposure than BCP
  • BCP higher peak but Evra higher overall
  • No proof
  • Dont cut in ½
  • Which risk?
  • BCP 1/200K
  • Evra 2-3/200k
  • Pregnancy 26/200K

35
  • The risk of dying from a pregnancy related
    complication (1/2 of all pregnancies are
    unplanned) is higher than for ALL causes of death
    associated with all contraceptive use.

36
(No Transcript)
37
DIABETES WARS
38
Diabetes
  • Exubra
  • Symlin
  • Byetta
  • Insulin Detamir
  • Pargluva
  • Sitagliptin

39
Exubera
  • 5 million Americans use insulin
  • Tested in both DM I and II
  • 2 years 3500 patients
  • Difference in A1c less than 0.5 versus injected
  • Rapid onset
  • Pulmonary ?

40
Exubera
  • Meal time only
  • Patients prefer
  • Smokers NO
  • Inhaler concerns
  • Cough
  • PFT
  • Insulin Antibody

41
Symlin (pramlintide)
  • New Class - Amlyinomimetic
  • Injectable cannot mix with insulin
  • Reduces fluctuations
  • No weight gain
  • Hypoglycemia, esp. with type I
  • Reduce insulin dose on initiation

42
Byetta (exenatide)
  • First incretin mimetic
  • Glucagon-like peptide-1, or GLP-1 hormone
  • Lowers after-meal and fasting glucose
  • Not for use with insulin
  • Hypoglycemia 14-36 with sulfonylurea
  • Wholesale 147/187
  • Weight loss

43
Pargluva (muraglitazar)
  • FDA - Approvable
  • New class glitazars
  • Type II DM
  • Activation of the PPARs
  • Decreases plasma glucose
  • Decreases FFA
  • Decreases Triglycerides
  • Increases HDL
  • JAMA Cleveland Clinic

44
Levemir
  • Ultra-long acting insulin detemir
  • BID dosing may be necessary
  • Phase III trials
  • Seeking approval in pediatrics

45
Sitagliptin
  • Dipeptidyl peptidase IV inhibitor
  • Phase II trials success
  • .6 - .8 reduction in A1c
  • Low wt gain
  • GI side effect, low hypoglycemia

46
Vaccines
  • Proquad
  • Rotavirus
  • Adacel
  • Boostrix
  • Cervarix
  • Gardasil
  • Zostavax

http//www.hhs.gov/nvpo/meetings/jun2003/zhou.ppt
1
47
ProQuad
  • MMR Varicella
  • 12 m to 12 yrs
  • 99 conversion
  • No ACIP recs
  • Side effects
  • Fever, rash similar
  • Less pain at site

48
Rotavirus
  • US 2.7 million infections
  • 70,000 hospitalizations
  • 20-70 deaths
  • RotaShield
  • RotaTeq
  • Genetic engineered
  • 3 dose, liquid
  • 5 strains
  • 98 effective

49
Boostrix
  • Diptheria, pertussis, tetanus
  • Pertussis on rise
  • 1/3 cases in age gt 10
  • Approved for age 10 - 18
  • ACIP age 11-12

50
Adacel
  • Tetanus, diphtheria and pertussis
  • Active booster - adults
  • Single dose
  • Ages 11- 64
  • Adverse similar to Td

51
Zostavax
  • ½ of 85 yr olds
  • Shingles Prevention Study
  • 5 yr study 3 yrs average
  • 38,500 patients, gt 60 yr
  • 51 RRR 1.8 ARR
  • NNT 55 shingles
  • NNT 344 for PNH
  • 200/wk Valtrex

52
Menactra
  • Meningococcus
  • ACIP 11-12 year olds
  • Replace menomune will last longer than 3-5
    years
  • applied for approval for use in children 2 to 10
    years

53
Cervical Cancer
  • Second most common cancer
  • 270,000 deaths annually
  • US
  • 1 million new infections
  • 20 million infected
  • 3,900 deaths
  • 6 BILLION

54
Cervarix vs. Gardasil
  • Fast track 12/05
  • HPV 16 18 AND
  • Genital wart 6,11
  • 0,2 6 months
  • NNT 250 _at_ 17 months
  • Submit in 2006
  • HPV 16 18
  • 70 of cancers
  • 0, 1, 6 month

Estimated cost 300
55
Antibiotics
  • Tygacil
  • New class Glyclcyclines
  • Cost 90/d
  • LevaPak - levofloxacin
  • ZMax
  • Single dose
  • CAP and ABS

56
Drugs Off Patent
  • Ambien - 2006
  • Fosamax - 2008
  • Zocor June 06
  • Zoloft 2006
  • Pravachol April 06
  • Norvasc July 06
  • Lipitor - 2009
  • Zofran Dec 06

57
Justsay No!
58
(No Transcript)
59
  • Campral
  • Acomplia
  • Champix
  • Varenicline
  • Commit

60
  • Paxil fetal heart defects
  • Crestor - rhabdomyolosis
  • Depo-Provera bone loss
  • Elidel and Protopic - lymphoma
  • NSAIDS MI
  • Strattera suicide
  • ADHD meds Sudden death
  • Salmeterol asthma attack

61
Congratulations Stealers!
62
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com